Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$3.36 - $5.34 $264,220 - $419,921
-78,637 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$3.3 - $6.49 $7,273 - $14,303
-2,204 Reduced 2.73%
78,637 $437,000
Q2 2021

Aug 12, 2021

BUY
$3.35 - $5.67 $270,817 - $458,368
80,841 New
80,841 $290,000

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $51.7M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.